Counterfeit cancer drugs can enter the market through various channels. These include illicit online pharmacies, unauthorized distributors, and even legitimate supply chains that have been compromised. The high cost and demand for cancer medications make them attractive targets for counterfeiters. Weak regulatory environments and lack of stringent enforcement also contribute to the problem.
